Home » Media Center » News » Gornitzky represents the underwriters in RedHill Biopharma’s USD 25 million public offering.

August 20, 2018

Gornitzky represents the underwriters in RedHill Biopharma’s USD 25 million public offering.

PDF

Gornitzky represented the sole underwriter, Ladenburg Thalmann, in RedHill Biopharma’s USD 25 million underwritten public offering of American Depositary Shares (ADSs) on the NASDAQ Global Market.

RedHill Biopharma Ltd., a biopharmaceutical company primarily focused on the development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases, is dually traded on the NASDAQ and the Tel Aviv Stock Exchange (NASDAQ: RDHL, TASE: RDHL).
Ladenburg Thalmann acted as sole book-running manager for the offering.

Ladenburg Thalmann was represented by Chaim Friedland (Partner), Ari Fried (Partner), Nir Knoll (Associate) and Netanel Kahane (Associate).

Gornitzky represents the underwriters in RedHill Biopharma’s USD 25 million public offering.

KEY CONTACTS

Chaim Friedland

Ari Fried

Nir Knoll

Netanel Kahane

RELATED PRACTICES

RELATED NEWS & PUBLICATIONS

Our Impact

Aviram Handel – Lecture at the Conference of the Court Administration for Legal Assistants at the Tel Aviv District Court

MICA Conference

Bittax

Institute of Business Arbitration Conference

Our firm represented Melisron Ltd. in a raise public debt of approximately 750 million NIS

The Jerusalem District Court approved foreign arbitration awards totaling approximately 100,000,000 NIS in favor of Hilton Worldwide against the French businessman Michel Ohayon

Gornitzky represented the underwriters in Similarweb’s USD 31.6 million secondary public offering on NYSE.

A lawsuit was filed for hundreds of thousands of shekels against tenants who refused to pay rent and management fees

Filing an appeal Against the Disqualification of Judge Amit from issuing a Ruling in the High Court of Justice

Accompaniment of OPC in the submission of a tender offer Sorek 3

Medical Center Transaction